Back to dashboard
MedicaidPrior AuthMedium impact

Authorization for Palivizumab - 2019-2020 Respiratory Syncytial Virus Season pdf

Connecticut Medicaid (HUSKY Health)·CT · Pediatrics, Pulmonology·Prior Authorization
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

Connecticut Medicaid (HUSKY) requires prior authorization for palivizumab (Synagis®) injections for the 2019-2020 RSV season when provided on an outpatient basis. Specific PA forms must be completed and faxed to designated pharmacies or CHNCT depending on the provider type.

Action Required

Action needed
Immediately: Providers treating HUSKY members requiring palivizumab (Synagis®) must obtain prior authorization before outpatient administration. Complete the appropriate PA form (hospital or pharmacy version) and fax with clinical documentation to CHNCT at (203) 774-0549 for hospitals or to designated preferred pharmacies (CVS/Caremark or Walgreens) for other providers. Claims will be denied without proper prior authorization.

Affected Billing Codes

90378